Amy T. Wang, MD; Steven A. Smith, MD
Wang AT, Smith SA. In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone. Ann Intern Med. 2010;153:JC6–11. doi: https://doi.org/10.7326/0003-4819-153-12-201012210-02011
Download citation file:
Published: Ann Intern Med. 2010;153(12):JC6-11.
Cardiology, Geriatric Medicine, Heart Failure, Neurology, Stroke.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use